Rockefeller Capital Management L.P. Sangamo Therapeutics, Inc Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$4.27 - $6.39 $1,229 - $1,840	-288 Reduced 31.2%	635 $3,000
Q2 2022 Aug 12, 2022	SELL	$3.28 - $6.21 $3,647 - $6,905	-1,112 Reduced 54.64%	923 $3,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $320 - $482	44 Added 2.21%	2,035 $15,000
Q3 2021 Nov 12, 2021	BUY	$9.01 - $12.01 $13,433 - $17,906	1,491 Added 298.2%	1,991 $17,000
Q2 2021 Aug 10, 2021	SELL	$10.17 - $12.64 $25,425 - $31,600	-2,500 Reduced 83.33%	500 $5,000
Q1 2021 May 11, 2021	BUY	$10.88 - $17.05 $31,552 - $49,445	2,900 Added 2900.0%	3,000 $37,000
Q4 2020 Feb 12, 2021	SELL	$9.23 - $18.18 $8,399 - $16,543	-910 Reduced 90.1%	100 $1,000
Q2 2020 Aug 12, 2020	BUY	$6.21 - $11.83 $5,651 - $10,765	910 Added 910.0%	1,010 $9,000
Q3 2019 Nov 12, 2019	BUY	$9.05 - $12.22 $905 - $1,222	100 New	100 $1,000

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.